Extinction is still forever, but scientists at the biotech company Colossal Biosciences are trying what they say is the next ...

North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...

The American Association for the Advancement of Science has published the following letter addressing the growing zoonotic ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

Learn how CASGEVY, the first NHS-approved CRISPR gene therapy, treats sickle cell disease through a revolutionary genetic ...

The decision reinstates unscientific regulation of new plant varieties, contradicting not only decades of experimentation, ...

Johns Hopkins scientists say the innovation could bring 'new fruits, foods, and flavors' to an expanded global agricultural ...

The USA animal model market has reached a significant milestone, attaining an estimated valuation of USD 976.1 million in ...

As layoffs continue to strike biopharma outfits big and small, life sciences technology and service provider Cytiva is ...

CEOs, CIOs and CFOs are finding that “deep tech” is actively driving business innovation and profitability. From AI models ...

Colossal Biosciences has engineered mice with mammoth-like traits for living in cold climates. These mice have wavy, golden ...